HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management (Q37202856)

18 August 2017

1 reference

title

HIV-associated nephropathy: epidemiology, pathogenesis, diagnosis and management (English)

1 reference

HIV-associated nephropathy

18 August 2017

0 references

0 references

0 references

1 reference

1 reference

Mohamed G Atta

1

1 reference

PubMed ID

18588500

18 August 2017

Gregory M Lucas

series ordinal

2

1 reference

PubMed ID

18588500

18 August 2017

Derek M Fine

series ordinal

3

1 reference

18 August 2017

1 June 2008

1 reference

Expert Review of Anti-infective Therapy

18 August 2017

1 reference

18 August 2017

6

1 reference

18 August 2017

365-371

1 reference

18 August 2017

3

1 reference

Associated focal and segmental glomerulosclerosis in the acquired immunodeficiency syndrome.

18 August 2017

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

HIV-associated nephropathy is a late, not early, manifestation of HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Course and prognosis of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Presentation, pathology, and outcome of HIV associated renal disease in a specialist centre for HIV/AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

HIV-associated nephropathy in African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Renal involvement in patients infected with HIV: experience at San Francisco General Hospital.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Recent progress in HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

A cross-sectional study of HIV-seropositive patients with varying degrees of proteinuria in South Africa

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Unusual presentations of primary human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Expression of HIV-1 genes in podocytes alone can lead to the full spectrum of HIV-1-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Mapping a locus for susceptibility to HIV-1-associated nephropathy to mouse chromosome 3

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

HIV-associated nephropathy: case study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Survival during renal replacement therapy among African Americans infected with HIV type 1 in urban Baltimore, Maryland

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

HIV-1 infection initiates an inflammatory cascade in human renal tubular epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Clinicopathologic correlates of prednisone treatment of human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Prednisone improves renal function and proteinuria in human immunodeficiency virus-associated nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Cohort study of the treatment of severe HIV-associated nephropathy with corticosteroids

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

The effect of adjunctive corticosteroids for the treatment of Pneumocystis carinii pneumonia on mortality and subsequent complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Captopril and renal survival in patients with human immunodeficiency virus nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Long-term renal survival in HIV-associated nephropathy with angiotensin-converting enzyme inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Outcome of patients with human immunodeficiency virus on maintenance hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

Retinoic acid inhibits HIV-1-induced podocyte proliferation through the cAMP pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.6.3.365

21 January 2018

Identifiers

DOI

10.1586/14787210.6.3.365

1 reference

18 August 2017

1 reference

PubMed ID

18588500